Search

everythinglearnresearchcommunity

for

Search:↓

Micrografts are a safe and effective treatment for hair loss in both men and women.

Low-dose oral minoxidil is effective and generally safe for treating hair loss in women.

Androgenetic alopecia is a genetic hair loss condition, more severe in men, and can also be caused by hormonal imbalances in women.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Androgenetic alopecia causes significant psychological distress, especially in women, and requires both medical and psychological support.

A genetic region near the PAX1 gene is linked to a higher risk of scoliosis in females.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

Androgenetic alopecia is a common form of hair loss in both men and women.

Start low-dose minoxidil gradually, especially for women, to reduce side effects.

Topical minoxidil and oral finasteride and dutasteride are the most effective treatments for male and female pattern hair loss, but study quality varies.

Trichoscopy helps diagnose and track treatment for hair loss in men and women.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Platelet-rich plasma injections effectively treat hair loss in both men and women, increasing hair density with high patient satisfaction and no significant side effects.

Galenic lotions can effectively treat different patterns of hair thinning in men and women.

Androgenetic alopecia is linked to higher cholesterol in both sexes and obesity in women.

Early hair loss in men may signal broader health issues similar to PCOS in women.

Men with early hair loss may have higher health risks similar to women with PCOS.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Androgenetic alopecia is a common form of hair loss in both men and women.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Growth factors greatly affect hair loss, with different levels seen in men, women, younger patients, and at the start of the condition.

Smoking and lighter hair color increase alopecia risk, especially in women and those over 25.

The SULT1A1 enzyme booster improves minoxidil effectiveness in treating hair loss, especially in females.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Hair loss in adults is linked to heart disease risk factors like unhealthy blood fats, lack of exercise, and alcohol use. It's also slightly more common in people with metabolic syndrome. As people age, hair loss gets worse. In men, severe hair loss is tied to high blood pressure and a larger waist. In women, it's tied to higher body weight. People with hair loss should be checked for unhealthy blood fats and advised to avoid alcohol and inactivity.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

Platelet-rich plasma injections can effectively reduce hair thinning, especially in women.

Hair loss can cause significant social and emotional issues, especially for women and young men.